Stefanie Senger

908 total citations
20 papers, 588 citations indexed

About

Stefanie Senger is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Stefanie Senger has authored 20 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Stefanie Senger's work include Heart Failure Treatment and Management (9 papers), Cardiovascular Function and Risk Factors (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Stefanie Senger is often cited by papers focused on Heart Failure Treatment and Management (9 papers), Cardiovascular Function and Risk Factors (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Stefanie Senger collaborates with scholars based in United States, Italy and Canada. Stefanie Senger's co-authors include Beth A. Davison, Marco Metra, Gad Cotter, John R. Teerlink, Andrzej Kawecki, JB Vermorken, Stephan Störkel, Sylvie Rottey, Lisa Licitra and Fernando Rivera and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Stefanie Senger

20 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie Senger United States 13 242 174 150 128 86 20 588
Allan Johansen Denmark 17 260 1.1× 111 0.6× 77 0.5× 55 0.4× 15 0.2× 51 802
Jin Lü China 12 61 0.3× 86 0.5× 145 1.0× 43 0.3× 46 0.5× 36 380
C Baughan United Kingdom 7 154 0.6× 140 0.8× 505 3.4× 91 0.7× 9 0.1× 9 864
Louise E. Daly Ireland 12 25 0.1× 168 1.0× 525 3.5× 102 0.8× 38 0.4× 35 1.3k
David J. Reeves United States 14 46 0.2× 187 1.1× 171 1.1× 125 1.0× 8 0.1× 38 461
Laura Healy Ireland 17 109 0.5× 254 1.5× 176 1.2× 119 0.9× 8 0.1× 33 1.1k
Peter H. Norman United States 16 97 0.4× 160 0.9× 54 0.4× 47 0.4× 6 0.1× 39 749
Özgür Akgül Türkiye 14 234 1.0× 75 0.4× 95 0.6× 83 0.6× 2 0.0× 36 490
Pieter de Heer Denmark 13 42 0.2× 162 0.9× 370 2.5× 115 0.9× 25 0.3× 21 916

Countries citing papers authored by Stefanie Senger

Since Specialization
Citations

This map shows the geographic impact of Stefanie Senger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Senger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Senger more than expected).

Fields of papers citing papers by Stefanie Senger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Senger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Senger. The network helps show where Stefanie Senger may publish in the future.

Co-authorship network of co-authors of Stefanie Senger

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Senger. A scholar is included among the top collaborators of Stefanie Senger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Senger. Stefanie Senger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mattos, Waldo, Nasreen Khalil, Lisa Spencer, et al.. (2024). Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 210(4). 435–443. 10 indexed citations
2.
Cotter, Gad, Beth A. Davison, Christopher Edwards, et al.. (2021). Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials. American Heart Journal. 240. 73–80. 1 indexed citations
3.
Bartúnek, Jozef, André Terzic, Beth A. Davison, et al.. (2020). Cardiopoietic Stem Cell Therapy in Ischaemic Heart Failure: Long-Term Clinical Outcomes. ESC Heart Failure. 7(6). 3345–3354. 26 indexed citations
4.
Teerlink, John R., Beth A. Davison, Gad Cotter, et al.. (2019). Effects of Serelaxin in Patients Admitted for Acute Heart Failure: A Meta-Analysis. European Journal of Heart Failure. 22(2). 315–329. 24 indexed citations
5.
Butler, Javed, Sean P. Collins, Gad Cotter, et al.. (2019). Is Plasma Renin Activity Associated with Worse Outcomes in Acute Heart Failure? A Secondary Analysis from the BLAST-AHF Trial. European Journal of Heart Failure. 21(12). 1561–1570. 10 indexed citations
6.
Davison, Beth A., Gary G. Koch, Stefanie Senger, et al.. (2019). 4329Mega-studies in heart failure, effect dilution in examination of new therapies. European Heart Journal. 40(Supplement_1). 1 indexed citations
7.
Gabbay, Vilma, Rachel D. Freed, Carmen Alonso, et al.. (2018). A Double-Blind Placebo-Controlled Trial of Omega-3 Fatty Acids as a Monotherapy for Adolescent Depression. The Journal of Clinical Psychiatry. 79(4). 44 indexed citations
8.
Metra, Marco, Gad Cotter, Stefanie Senger, et al.. (2018). Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion. Circulation Heart Failure. 11(5). e004644–e004644. 57 indexed citations
9.
Cotter, Gad, Marco Metra, Beth A. Davison, et al.. (2017). Systolic Blood Pressure Reduction During the First 24 H in Acute Heart Failure Admission: Friend or Foe?. European Journal of Heart Failure. 20(2). 317–322. 17 indexed citations
10.
11.
Cotter, Gad, Beth A. Davison, Javed Butler, et al.. (2017). Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF. Clinical Research in Cardiology. 107(2). 170–181. 33 indexed citations
12.
Davison, Beth A., Marco Metra, Stefanie Senger, et al.. (2016). Patient Journey After Admission for Acute Heart Failure: Length Of Stay, 30-Day Readmission and 90-Day Mortality. European Journal of Heart Failure. 18(8). 1041–1050. 52 indexed citations
13.
Carubelli, Valentina, Gad Cotter, Beth A. Davison, et al.. (2016). In-hospital worsening heart failure in patients admitted for acute heart failure. International Journal of Cardiology. 225. 353–361. 12 indexed citations
14.
Cotter, Gad, Beth A. Davison, Olga Milo, et al.. (2015). Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS. Journal of Cardiac Failure. 22(10). 815–822. 26 indexed citations
15.
Cotter, Gad, Marco Metra, Beth A. Davison, et al.. (2014). Worsening Heart Failure, a Critical Event During Hospital Admission for Acute Heart Failure: Results from the VERITAS Study. European Journal of Heart Failure. 16(12). 1362–1371. 23 indexed citations
16.
Horai, Takeshi, Ikuo Sekine, Nobuyuki Yamamoto, et al.. (2011). Safety of BLP25 Liposome Vaccine (L-BLP25) in Japanese Patients with Unresectable Stage III NSCLC after Primary Chemoradiotherapy: Preliminary Results from a Phase I/II Study. Japanese Journal of Clinical Oncology. 41(5). 718–722. 36 indexed citations
17.
Rossmann, Eva, Anders Österborg, Eva Löfvenberg, et al.. (2011). Randomized Phase II Study of BLP25 Liposome Vaccine (L-BLP25) in Patients with Multiple Myeloma. Blood. 118(21). 2927–2927. 1 indexed citations
18.
Buzaid, Antônio C., Sérgio D. Simon, Luis Fein, et al.. (2010). Cetuximab Plus Irinotecan in Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: The LABEL Study. Clinical Colorectal Cancer. 9(5). 282–289. 10 indexed citations
19.
20.
Horai, Takeshi, Ikuo Sekine, Norio Yamamoto, et al.. (2010). L-BLP25 for unresectable stage III non-small cell lung cancer after primary chemoradiotherapy in Japanese patients: Preliminary safety results from a phase I/II study.. Journal of Clinical Oncology. 28(15_suppl). e13153–e13153. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allan Johansen Breakdown of academic impact, for papers by Jin Lü Breakdown of academic impact, for papers by C Baughan Breakdown of academic impact, for papers by Louise E. Daly Breakdown of academic impact, for papers by David J. Reeves Breakdown of academic impact, for papers by Laura Healy Breakdown of academic impact, for papers by Peter H. Norman Breakdown of academic impact, for papers by Özgür Akgül Breakdown of academic impact, for papers by Pieter de Heer
Rankless by CCL
2026